from24/7 Wall St.3 days agoGrowth hackingHims & Hers Shows It's More Than Just GLP-1 DrugsHims & Hers posted a substantial growth in revenue and profits, leading to an 18% stock surge.The company is focusing on long-term growth with significant increase in subscribers and monetization.
from24/7 Wall St.5 days agoHealthcareHims & Hers (HIMS) Blows Out Earnings ExpectationsHims & Hers Health reports strong Q1 2025 performance with 111% revenue increase year-over-year and robust subscriber growth.
from24/7 Wall St.3 days agoGrowth hackingHims & Hers Shows It's More Than Just GLP-1 DrugsHims & Hers posted a substantial growth in revenue and profits, leading to an 18% stock surge.The company is focusing on long-term growth with significant increase in subscribers and monetization.
from24/7 Wall St.5 days agoHealthcareHims & Hers (HIMS) Blows Out Earnings ExpectationsHims & Hers Health reports strong Q1 2025 performance with 111% revenue increase year-over-year and robust subscriber growth.